We are live on ! Find out more
S

Sanofi Portfolio holdings

AUM $336M
1-Year Est. Return 126.85%
This Fund
S&P 500
This Quarter Est. Return
+1%
1 Year Est. Return
+126.85%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$174M
AUM Growth
–
Cap. Flow
+$208M
Cap. Flow %
119.34%
Top 10 Hldgs %
100%
Holding
9
New
9
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
MGTX icon
MeiraGTx Holdings
MGTX
+$71.5M
2
NVAX icon
Novavax
NVAX
+$66.3M
3
ANAB icon
AnaptysBio
ANAB
+$19.9M
4
INBX icon
Inhibrx
INBX
+$17.6M
5
IGMS
IGM Biosciences
IGMS
+$17.1M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MGTX icon
1
MeiraGTx Holdings
MGTX
$1.14B
$74.3M 42.6%
+12,197,737
New +$71.5M
NVAX icon
2
Novavax
NVAX
$1.23B
$55.3M 31.73%
+6,880,481
New +$66.3M
INBX icon
3
Inhibrx
INBX
$1.21B
$17.8M 10.23%
+1,157,926
New +$17.6M
ANAB icon
4
AnaptysBio
ANAB
$1.59B
$10.9M 6.24%
+821,917
New +$19.9M
IGMS
5
DELISTED
IGM Biosciences
IGMS
$8.79M 5.04%
+1,438,975
New +$17.1M
ELDN icon
6
Eledon Pharmaceuticals
ELDN
$276M
$3.36M 1.93%
+814,980
New +$3.21M
LVTX
7
DELISTED
LAVA Therapeutics
LVTX
$1.83M 1.05%
+1,919,455
New +$3.01M
INZY
8
DELISTED
Inozyme Pharma
INZY
$1.23M 0.7%
+443,255
New +$1.69M
QTTB icon
9
Q32 Bio
QTTB
$452M
$840K 0.48%
+244,083
New +$7.71M

Similar funds

LFP
Leeward Financial Partners Bellevue, Washington $336M AUM 20.94% 1-Year Est. Return
HFS
Haverford Financial Services Radnor, Pennsylvania $336M AUM 20.46% 1-Year Est. Return
SG
Standard General New York $336M AUM 16.52% 1-Year Est. Return
TH
Team Hewins Redwood City, California $337M AUM 24.42% 1-Year Est. Return
SC
Schiavi & Co Wilmington, Delaware $337M AUM 16.69% 1-Year Est. Return
SIC
Shoker Investment Counsel Oxford, Ohio $337M AUM 24.9% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return
PCM
Passive Capital Management Baltimore, Maryland $335M AUM 12.6% 1-Year Est. Return

Sanofi's Q4 2024 Portfolio in Review

Q4 2024 is the first quarter with a 13F filing on record for Sanofi, which disclosed 9 positions worth $174M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is MeiraGTx Holdings: 12,197,737 shares worth $74.3M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Sanofi's largest Q4 2024 buy was MeiraGTx Holdings: 12,197,737 shares worth $74.3M.
  • Sanofi's ten largest holdings make up 100% of its $174M portfolio in Q4 2024.
  • Sanofi disclosed 9 positions in Q4 2024, its first 13F filing on record.

Based on Sanofi's 13F filing for Q4 2024, filed 14 Feb 2025.